Literature DB >> 17084639

The adipocyte-myocyte axis in insulin resistance.

Henrike Sell1, Daniela Dietze-Schroeder, Jürgen Eckel.   

Abstract

Insulin resistance in skeletal muscle is linked to an elevated adipose tissue mass, as is found in obesity, but can also be observed in lipodystrophy, in which adipose tissue is greatly reduced. Adipose tissue releases endocrine and metabolic mediators and is actively involved in crosstalk with skeletal muscle, a process that precedes and underlies the development of insulin resistance in muscles. Adipokines including tumor necrosis factor alpha, interleukin-6, leptin and adiponectin influence insulin signaling in skeletal muscle. Free fatty acids, their metabolites and ectopic fat in muscle also contribute to insulin resistance. Recent research indicates inflammation, endoplasmic reticulum stress and oxidative stress could be underlying mechanisms at the center of the development of insulin resistance. Insights into the role of macrophages in adipose tissue add to the complicated interplay between adipose tissue and skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084639     DOI: 10.1016/j.tem.2006.10.010

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  42 in total

1.  Physiology of Mechanotransduction: How Do Muscle and Bone "Talk" to One Another?

Authors:  Janalee Isaacson; Marco Brotto
Journal:  Clin Rev Bone Miner Metab       Date:  2014-06

2.  Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance.

Authors:  Chao-Ping Wang; Fu-Mei Chung; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2007-08-10

3.  Chemerin receptor blockade improves vascular function in diabetic obese mice via redox-sensitive and Akt-dependent pathways.

Authors:  Karla Bianca Neves; Aurelie Nguyen Dinh Cat; Rheure Alves-Lopes; Katie Yates Harvey; Rafael Menezes da Costa; Nubia Souza Lobato; Augusto Cesar Montezano; Ana Maria de Oliveira; Rhian M Touyz; Rita C Tostes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-09-14       Impact factor: 4.733

4.  Arsenic-stimulated lipolysis and adipose remodeling is mediated by G-protein-coupled receptors.

Authors:  D Yesica Garciafigueroa; Linda R Klei; Fabrisia Ambrosio; Aaron Barchowsky
Journal:  Toxicol Sci       Date:  2013-05-06       Impact factor: 4.849

5.  Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.

Authors:  Takashi Shida; Kentaro Akiyama; Sechang Oh; Akemi Sawai; Tomonori Isobe; Yoshikazu Okamoto; Kazunori Ishige; Yuji Mizokami; Kenji Yamagata; Kojiro Onizawa; Hironori Tanaka; Hiroko Iijima; Junichi Shoda
Journal:  J Gastroenterol       Date:  2017-08-08       Impact factor: 7.527

6.  Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture.

Authors:  B Vandanmagsar; K R Haynie; S E Wicks; E M Bermudez; T M Mendoza; D Ribnicky; W T Cefalu; R L Mynatt
Journal:  Diabetes Obes Metab       Date:  2014-03-10       Impact factor: 6.577

Review 7.  Nonischemic heart failure in diabetes mellitus.

Authors:  Ashrith Guha; Romain Harmancey; Heinrich Taegtmeyer
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

8.  In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Kinya Seo; Hiroshi Yamashita; Yumiko Hosoya; Mitsuru Ohsugi; Kazuyuki Tobe; Takashi Kadowaki; Ryozo Nagai; Seiryo Sugiura
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

9.  Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells.

Authors:  Henrike Sell; Jurga Laurencikiene; Annika Taube; Kristin Eckardt; Andrea Cramer; Angelika Horrighs; Peter Arner; Jürgen Eckel
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

10.  Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study.

Authors:  Christian Herder; Eric J Brunner; Wolfgang Rathmann; Klaus Strassburger; Adam G Tabák; Nanette C Schloot; Daniel R Witte
Journal:  Diabetes Care       Date:  2008-12-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.